22nd Century Group, Inc. (XXII) Stock Price & Analysis
22nd Century Group, Inc. (XXII) fell 29.25% to USD 0.37 as of June 10, 2026 at 01:59 UTC, according to Nexqual real-time market data.
XXII last closed at USD 0.52; the session ranged USD 0.36–0.44 on volume of 1,171,014 shares. Market capitalization is $1.63M, with a 52-week range of USD 0.36–248.4 (NCM). Source: Nexqual, June 10, 2026 at 01:59 UTC.
Key Statistics (as of June 10, 2026 at 01:59 UTC)
| Price | USD 0.37 |
|---|---|
| Change | ▼ 29.25% (down) |
| Previous Close | USD 0.52 |
| Open | USD 0.43 |
| Day Range | USD 0.36 – 0.44 |
| 52-Week Range | USD 0.36 – 248.4 |
| Volume | 1,171,014 shares |
| Market Cap | $1.63M |
| Exchange | NCM |
Technical Analysis (XXII)
Nexqual's technical model rates XXII "SELL" based on 3 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 01:59 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 18.07 (oversold) |
| vs SMA50 | Below (USD 1.27) |
| MACD | -0.26 (negative) |
Analyst Ratings (XXII)
Wall Street analysts rate XXII "None", per Nexqual as of June 10, 2026 at 01:59 UTC.
| Consensus Rating | None |
|---|
Earnings (XXII)
| Next Earnings Date | 2026-05-07 |
|---|
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD -18.08 vs est -1.2 ▼ miss |
| 2025-12-31 | USD -5.89 vs est -2.1 ▼ miss |
Source: Nexqual, June 10, 2026 at 01:59 UTC.
Financials & Fundamentals (XXII)
| Total Revenue | $6.06M |
|---|---|
| Revenue Growth (YoY) | -43.30% |
| Gross Margin | -52.19% |
| Operating Margin | -235.76% |
| Profit Margin | -65.76% |
| ROE | -103.55% |
| Debt / Equity | 6.2 |
| Current Ratio | 2.67 |
| Total Cash | $9.54M |
| Total Debt | $1.32M |
| Free Cash Flow | $-13.15M |
Source: Nexqual, June 10, 2026 at 01:59 UTC.
Financial Health Score (XXII)
Nexqual rates 22nd Century Group, Inc.'s overall financial health "Weak" across five dimensions, as of June 10, 2026 at 01:59 UTC.
| Growth | Critical — Revenue -43% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Strong — $10M cash vs $1M debt, net cash position |
| Cash Flow | Weak — FCF negative: -$13M, burning cash |
| Efficiency | Critical — ROE -104%, ROA -28.3% |
Ownership (XXII)
| Insider Ownership | +0.42% |
|---|---|
| Institutional Ownership | +1.90% |
| Shares Outstanding | 4.46M |
| Float | 4.46M |
| Short % of Float | +1.33% |
Source: Nexqual, June 10, 2026 at 01:59 UTC.
Leadership (XXII)
22nd Century Group, Inc. is led by Lawrence D. Firestone (age 67), President, CEO & Chairman, per Nexqual as of June 10, 2026 at 01:59 UTC.
| President, CEO & Chairman | Lawrence D. Firestone (age 67) |
|---|---|
| CFO & Principal Accounting Officer | Daniel A. Otto (age 35) |
| Vice President of Operations | Scott Marion (age 44) |
| Senior Vice President of Sales & Marketing | Robert P. Manfredonia (age 60) |
| Director of Science & Technology | Kimberly Farr |
Major Backers & Investors (XXII)
Notable institutional backers of 22nd Century Group, Inc. include Anson Funds Management LP, Fidelity, according to Nexqual as of June 10, 2026 at 01:59 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Anson Funds Management LP | 1.14% |
| Fidelity | 0.34% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Geode Capital | 0.35% |
Source: Nexqual, June 10, 2026 at 01:59 UTC.
From 22nd Century Group, Inc.'s Latest SEC 10-K Filing (filed 2026-03-26)
Key Strengths & Strategy (as disclosed to the SEC)
- 22nd Century Group, Inc., a tobacco products company, manufactures, distributes, and sells proprietary new reduced nicotine tobacco products in the United States.
- The company offers reduced nicotine content tobacco and very low nicotine combustible cigarette products.
- It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands, as well as turnkey contract manufacturing of cigarettes and filtered cigars for other established tobacco brands. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Mocksville, North Carolina.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| TVRD | Tvardi Therapeutics, Inc. | USD 2.78 | ▼ 3.81% |
| DOGP | Dogecoin Cash Inc. | USD 0.01 | ▼ 28.57% |
| CANN | TREES Corporation | USD 0.02 | ▲ 30.43% |
| CVSI | CV Sciences, Inc. | USD 0.03 | ▼ 3.33% |
| IGC | IGC Pharma, Inc. | USD 0.29 | ▼ 1.72% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 01:59 UTC. This page is informational and not investment advice.